Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

O blood group is a risk factor for severe mucosal hemorrhage in orally anticoagulated patients

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Franchini M, Favaloro EJ, Targher G, Lippi G (2012) ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 49:137–149

  2. 2.

    Wu O, Bayoumi N, Vickers MA, Clark P (2008) ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 6:2–69

  3. 3.

    Dentali F, Sironi AP, Ageno W et al (2012) Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 38:535–548

  4. 4.

    Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691–1695

  5. 5.

    Dentali F, Sironi AP, Ageno W et al (2012) Relationship between ABO blood group and hemorrhage: a systematic review and meta-analysis. Semin Thromb Hemost [Epub ahead of print]

  6. 6.

    Garcia AA, van der Heijden JF, Meijers JCM, Rosendaal FR, Reitsma PH (2006) The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment. J Thromb Haemost 4:1418–1420

  7. 7.

    Pruissen DMO, Rosendaal FR, Gorter JW, Garcia AA, Kappelle LJ, Algra A; for the SPIRIT Study Group (2007) Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin. J Neurol 254:1660–1665

  8. 8.

    Franchini M, Crestani S, Frattini F, Mengoli C, Bonfanti C (2012) Relationship between ABO blood group and bleeding complications in orally anticoagulated patients. J Thromb Haemost 10:1688–1691

  9. 9.

    Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214

  10. 10.

    Franchini M, Crestani S, Rossi C et al (2012) O blood group and the risk of major bleeding: a single-center survey. J Thromb Thrombolysis [Epub ahead of print]

  11. 11.

    Franchini M, Mannucci PM (2008) Von Willebrand factor: another janus-faced hemostasis protein. Semin Thromb Hemost 34:663–669

Download references

Author information

Correspondence to Massimo Franchini.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Franchini, M., Rossi, C., Mengoli, C. et al. O blood group is a risk factor for severe mucosal hemorrhage in orally anticoagulated patients. J Thromb Thrombolysis 36, 358–360 (2013). https://doi.org/10.1007/s11239-012-0855-y

Download citation

Keywords

  • Blood Group
  • Oral Anticoagulant Therapy
  • Anticoagulated Patient
  • Coagulation Factor VIII
  • Bleeding Risk Factor